tiprankstipranks
Trending News
More News >
BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
US Market

BioNano Genomics (BNGO) Income Statement

Compare
9,186 Followers

BioNano Genomics Income Statement

Last quarter (Q1 2025), BioNano Genomics's total revenue was $6.46M, a decrease of -26.37% from the same quarter last year. In Q1, BioNano Genomics's net income was $-3.10M. See BioNano Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 30.78M$ 36.12M$ 27.80M$ 17.98M$ 8.50M
Gross Profit
$ 380.00K$ 9.57M$ 5.95M$ 3.87M$ 2.77M
Operating Expenses
$ 104.36M$ 224.81M$ 137.64M$ 80.97M$ 41.32M
Depreciation and Amortization
$ 14.23M$ 13.71M$ 10.10M$ 3.97M$ 1.47M
EBITDA
$ -97.47M$ -213.60M$ -120.31M$ -73.86M$ -37.08M
Operating Income
$ -103.98M$ -215.25M$ -131.70M$ -77.10M$ -38.55M
Other Income/Expenses
$ -8.00M$ -17.19M$ 986.00K$ -1.05M$ -2.53M
Pretax Income
$ -111.98M$ -232.43M$ -130.71M$ -78.15M$ -41.11M
Net Income
$ -112.02M$ -232.49M$ -132.60M$ -72.44M$ -41.14M
Per Share Metrics
Basic EPS
$ -60.05$ -408.48$ -275.09$ -157.02$ -236.58
Diluted EPS
$ -60.05$ -408.60$ -275.09$ -157.02$ -236.58
Weighted Average Shares Outstanding
1.87M 569.00K 482.02K 461.30K 173.75K
Weighted Average Shares Outstanding (Diluted)
1.87M 569.17K 482.02K 461.30K 173.75K
Currency in USD

BioNano Genomics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis